“…Individually, these modifications can introduce a significant amount of heterogeneity in the final product, and it is likely that mixtures of multiple modifications will coexist in finished products that may ultimately increase upon storage or degradation. 1,4,7,8 Consequently, it is critical to characterize such molecules from the amino acid sequence to structural conformation to ensure clinically significant bioactivity, drug effectiveness, and quality. Common techniques used to analyze mAbs include chromatographic methods such as size exclusion chromatography, ion-exchange chromatography, reversed-phase liquid chromatography, and electrophoresis based methods such as isoelectric focusing, gel electrophoresis, and capillary zone electrophoresis.…”